Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natalia D. Selezneva"'
Autor:
Boris B. Velichkovsky, Alena A. Khlebnikova, Dmitry V. Tatarinov, Natalia D. Selezneva, Gavrilova Si, Roshchina If
Publikováno v:
Psychology in Russia: State of the Art. 13:109-120
Publikováno v:
Experimental gerontology. 135
Task switching performance was assessed in a group of healthy young, healthy old, and MCI-diagnosed participants. Highly significant RT-related local switch costs were found in the MCI group. This contrasts the typical finding that in normal aging lo
Autor:
Natalia D. Selezneva, U A Gutner, Alisa Alesenko, Elena Ponomareva, Gavrilova Si, Yana Fedorova, Maria Shupik, Alena Lebedeva, Igor V. Kolykhalov
Publikováno v:
Neuroscience for Medicine and Psychology.
Publikováno v:
Psychology in Russia: State of Art, Vol 8, Iss 1, Pp 4-13 (2015)
A major risk factor for late-onset Alzheimer’s type dementia (DAT) is the carriage of the ε4 allele of the apolipoprotein E (ApoE) gene. Identifying cognitive deficits in healthy ApoE-ε4 carriers is valuable in order to develop interventions to p
Autor:
I. S. Boksha, Natalia D. Selezneva, Serge N. Miasoedov, Igor V. Kolykhalov, Iana B. Fedorova, Iaroslav B. Kalyn, Elizabeta B. Mukaetova-Ladinska, Gavrilova Si, Andrei V. Samorodov
Publikováno v:
Health. :2581-2591
Objectives: Although people with amnestic mild cognitive impairment (aMCI) benefit from cerebrolysin treatment, some still develop dementia. The aim of the current study was to identify most informative clinical assessment tests to predict the therap
Autor:
Konstantin G. Skryabin, Artem V. Artemov, N. M. Gruzdeva, Nikolay Chekanov, Svetlana V. Tsygankova, Boris B. Velichkovsky, Eugenia S. Boulygina, Natalia D. Selezneva, Egor Prokhortchouk, Gavrilova Si, Artem V. Nedoluzhko, Roshchina If
Publikováno v:
Human Genome Variation
We report a family case of type II early-onset Alzheimer’s disease (AD) inherited over three generations. None of the patients in the family had mutations in the genes believed to be the major risk factors for AD, such as APP, presenilin 1 or 2. Ta
Publikováno v:
European Heart Journal; Sep2006, Vol. 27 Issue 18, p2224-2231, 8p